| URL | https://www.biospace.com/article/releases/bright-p |
| Source | BioSpace |
| Date Published | 12/13/2023 |
| Company/Division name | Bright Path Laboratories |
| Parent company | Bright Path Laboratories |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2023 |
| City reshored to: | Kannapolis |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Cancer drugs |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption |